Aaron Bean
Foot & Ankle Surgery · la Quinta, CANPI 1245568476
Payments from drug & device makers
Across 26 payments — averaging $875.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Team_makena_llc$21K
- Paragon 28, Inc.$296
- Stryker$243
- Shockwave Medical, Inc$191
- Trilliant Surgical LLC.$155
- Smith+Nephew$140
- plus $453 from 12 others
What the payments were for
- Speaking & faculty fees$21,28394%
- Food & beverage$1,4796%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Team_makena_llc | 1 | $21,283 |
| Paragon 28, Inc. | 2 | $296 |
| Stryker(2 entities) | 3 | $243 |
| Shockwave Medical, Inc | 1 | $191 |
| Trilliant Surgical LLC. | 1 | $155 |
| Smith+Nephew | 3 | $140 |
| Medline Industries LP | 1 | $77 |
| Nevro Corp. | 3 | $62 |
| Abbott | 2 | $52 |
| Linvatec Corporation | 1 | $50 |
| Integra Lifesciences Corporation | 1 | $36 |
| Organogenesis Inc. | 1 | $34 |
| Vertex | 1 | $29 |
| GSK | 1 | $26 |
| Acell, Inc. | 1 | $24 |
| Treace Medical Concepts, Inc. | 1 | $24 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$191
- Arsenal$155
- SMART28$155
- APEX 3D$142
- MICA$120
How this compares
$22,762 in reported general payments places this provider in the 90th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 101 | $1,146 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 75 | $660 |
| Gabapentin | 38 | $285 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 21 | $250 |
| Methylprednisolone | 25 | $185 |
| Ondansetron OdtOndansetron | 14 | $164 |
| Oxycodone Hcl | 21 | $105 |
| Tramadol Hcl | 14 | $42 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in la Quinta
- John ZimmermanBakersfield$4.6M
- Eric GizaSacramento$3.7M
- Thomas HarrisPasadena$3M
- Felix SigalLos Angeles$2.2M
- Thomas ChangSanta Rosa$2.1M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.